Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Genetics (7)
- Gene expression (3)
- Classification (2)
- Feature selection (2)
- Genomics (2)
-
- Microarray (2)
- Survival analysis (2)
- Alcoholic liver disease (1)
- BLUPs; Kernel function; Model/variable selection; Nonparametric regression; Penalized likelihood; REML; Score test; Smoothing parameter; Support vector machines (1)
- Bayesian (1)
- Bayesian Additive Regression Trees (1)
- Bayesian Inference (1)
- Bayesian Significance Testing (1)
- Bayesian random-effects meta-analysis model (1)
- Bayesian shrinkage priors (1)
- Bayesian trees (1)
- Binswanger's Disease (1)
- Bioinformatics (1)
- Biomarker (1)
- Biomarkers; Variable Importance; Targeted Maximum Likelihood; Standard Method (1)
- Biomedical signal processing (1)
- Biostatistics (1)
- Brain tumor (1)
- Breast cancer (1)
- Cancer genomics (1)
- Case-Cohort Design (1)
- Clinical trials (1)
- Conditional Independence (1)
- Covariance selection (1)
- Crossing hazards (1)
- Publication Year
- Publication
-
- Harvard University Biostatistics Working Paper Series (6)
- COBRA Preprint Series (5)
- Electronic Theses and Dissertations (4)
- Theses and Dissertations (4)
- Dissertations and Theses (Open Access) (3)
-
- U.C. Berkeley Division of Biostatistics Working Paper Series (2)
- Annual Symposium on Biomathematics and Ecology Education and Research (1)
- Biostatistics Faculty Publications (1)
- Graduate Research Posters (1)
- Graduate Theses and Dissertations (1)
- Mathematics & Statistics ETDs (1)
- UW Biostatistics Working Paper Series (1)
- Yale Day of Data (1)
- Publication Type
Articles 31 - 31 of 31
Full-Text Articles in Microarrays
New Statistical Paradigms Leading To Web-Based Tools For Clinical/Translational Science, Knut M. Wittkowski
New Statistical Paradigms Leading To Web-Based Tools For Clinical/Translational Science, Knut M. Wittkowski
COBRA Preprint Series
As the field of functional genetics and genomics is beginning to mature, we become confronted with new challenges. The constant drop in price for sequencing and gene expression profiling as well as the increasing number of genetic and genomic variables that can be measured makes it feasible to address more complex questions. The success with rare diseases caused by single loci or genes has provided us with a proof-of-concept that new therapies can be developed based on functional genomics and genetics.
Common diseases, however, typically involve genetic epistasis, genomic pathways, and proteomic pattern. Moreover, to better understand the underlying biologi-cal …